Abstract:CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated) systems are RNA-guided adaptive immunity pathways used by bacteria and archaea to defend against phages and plasmids. Type III-A systems use a multisubunit interference complex called Csm, containing Cas proteins and a CRISPR RNA (crRNA) to target cognate nucleic acids. The Csm complex is intriguing in that it mediates RNA-guided targeting of both RNA and transcriptionally active DNA, but the mechanism is not well understood. Here, we overexpressed the five components of the Thermus thermophilus (T. thermophilus) Type III-A Csm complex (TthCsm) with a defined crRNA sequence, and purified intact TthCsm complexes from E. coli cells. The complexes were thermophilic, targeting complementary ssRNA more efficiently at 65°C than at 37°C. Sequence-independent, endonucleolytic cleavage of single-stranded DNA (ssDNA) by TthCsm was triggered by recognition of a complementary ssRNA, and required a lack of complementarity between the first 8 nucleotides (5' tag) of the crRNA and the 3' flanking region of the ssRNA. Mutation of the histidine-aspartate (HD) nuclease domain of the TthCsm subunit, Cas10/Csm1, abolished DNA cleavage. Activation of DNA cleavage was dependent on RNA binding but not cleavage. This leads to a model in which binding of an ssRNA target to the Csm complex would stimulate cleavage of exposed ssDNA in the cell, such as could occur when the RNA polymerase unwinds double-stranded DNA (dsDNA) during transcription. Our findings establish an amenable, thermostable system for more in-depth investigation of the targeting mechanism using structural biology methods, such as cryo-electron microscopy and x-ray crystallography.

Cmr1 enables efficient RNA and DNA interference of a III-B CRISPR–Cas system by binding to target RNA and crRNA

Københavns Universitet Cmr 1 enables efficient RNA and DNA interference of a IIIB CRISPR – Cas system by binding to target RNA and crRNA

A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction

Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas

Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system

Molecular Mechanisms Of Iii-B Crispr-Cas Systems In Archaea

An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover

Inactivation of Target RNA Cleavage of a III-B CRISPR-Cas System Induces Robust Autoimmunity in Saccharolobus islandicus

RNA activation‐independent DNA targeting of the Type III CRISPR‐Cas system by a Csm complex

Structure and function of a bacterial type III-E CRISPR–Cas7-11 complex

Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

AcrIIIA1 is a protein-RNA anti-CRISPR complex that targets core Cas and accessory nucleases

Structural insight into the Csx1-Crn2 fusion self-limiting ribonuclease of type III CRISPR system

A type III-A CRISPR–Cas system mediates co-transcriptional DNA cleavage at the transcriptional bubbles in close proximity to active effectors

Target RNA-guided protease activity in type III-E CRISPR–Cas system

Exploiting activation and inactivation mechanisms in type I-C CRISPR-Cas3 for genome-editing applications

Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers

RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System

Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex

Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6

Target RNA activates the protease activity of Craspase to confer antiviral defense